Archive for: Regulatory

Diagonal Bio announces strategic pilot study with Löberöds Hästklinik

, , , ,
Diagonal Bio AB (publ) (“Diagonal Bio” or “the Company”) is pleased to announce a significant new collaboration with Löberöds Hästklinik, led by renowned sporthorse veterinarian Lisa Lidbeck. The agreement,…

Diagonal Bio AB Annual Report 2023

, , , , ,
The Board of Directors and CEO of Diagonal Bio AB hereby publish the Annual Report for the fiscal year 2023. The Annual Report is available as an attached file to this release and on Diagonal Bio’s website (www.diagonalbio.com/investors/financial-reports).Documents  Diagonal…

Kallelse till årsstämma i Diagonal Bio AB

, , ,
Aktieägarna i Diagonal Bio AB (publ), org.nr 559248-8984, (”Bolaget”) kallas härmed till årsstämma tisdagen den 11 juni 2024 kl. 13.00. Stämman hålls på Medicon Village, Scheeletorget 1 i Lund.Rätt…

Diagonal Bio AB announces last day of trading in BTU and first day of trading in TO 1

, , ,
Diagonal Bio AB's ("Diagonal Bio" or the "Company") rights issue of units, with a subscription period ending on April 22, 2024, has now been registered at the Swedish Companies Registration Office. The Company hereby announces that the last…

Diagonal Bio AB announces outcome of rights issue

, , , ,
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, RUSSIA, BELARUS OR ANY OTHER JURISDICTION…

The subscription period in Diagonal Bio AB rights issue commences today

, , ,
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, RUSSIA, BELARUS OR ANY OTHER JURISDICTION…

Diagonal Bio announces successful pilot study results and extended partnership with Hørsholm Veterinary Clinic

, , , ,
Diagonal Bio AB (publ) (“Diagonal Bio” or “the Company”) announces the extension of its partnership with Hørsholm Veterinary Clinic following the successful completion of a three-month pilot study. The pilot study…

Diagonal Bio AB publishes a prospectus because of upcoming rights issue

, , ,
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR TO THE UNITED STATES, AUSTRALIA, HONG KONG, JAPAN, CANADA, NEW ZEALAND, SWITZERLAND, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, RUSSIA, BELARUS OR ANY OTHER JURISDICTION…

Bulletin from the Extraordinary General Meeting on Tuesday 2[nd] of April in Diagonal Bio AB

, , ,
Today, 2[nd] April 2024, an Extraordinary General Meeting was held in Diagonal Bio AB, reg. no. 559248–8984. Below is a summary of the resolutions passed. All resolutions were passed with the required majority.The board's proposal on reducing…

Diagonal Bio appoints Karin Wehlin as new CEO

, , , ,
Diagonal Bio AB (publ.) (“Diagonal Bio” or “the Company”) is pleased to announce that the Board of Directors has appointed Karin Wehlin as Chief Executive Officer (CEO) of Diagonal Bio. Karin Wehlin is currently Diagonal…